Trv Gp Iii, LLC Decibel Therapeutics, Inc. Transaction History

Trv Gp Iii, LLC

  • $6.14 Million
  • Q4 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
BUY
$10.56 - $19.9 $33.2 Million - $62.5 Million
3,139,685 New
3,139,685 $35.7 Million

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Trv Gp Iii, LLC Portfolio

Follow Trv Gp Iii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Iii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Iii, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email